<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: psa screening</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Comorbidities should be factor in prostate biopsy choice, study finds</title>
   	 <description>UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities – the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) and the physician-reported Charlson Comorbidity Index – can successfully target prostate patients who would not benefit from biopsy to discover possible cancer.</description>
     <link>http://medicalxpress.com/news/2013-05-comorbidities-factor-prostate-biopsy-choice.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 15 May 2013 09:18:45 EST</pubDate>
	 <guid isPermaLink="false">news287828319</guid>
	 
</item>
<item>
     <title>Using genetic variants to improve PSA testing technique and reduce biopsies</title>
   	 <description>With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine.</description>
     <link>http://medicalxpress.com/news/2013-04-genetic-variants-psa-technique-biopsies.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 24 Apr 2013 15:47:26 EST</pubDate>
	 <guid isPermaLink="false">news286037239</guid>
	 
</item>
<item>
     <title>Nearly half of all deaths from prostate cancer can be predicted before age 50</title>
   	 <description>Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.</description>
     <link>http://medicalxpress.com/news/2013-04-deaths-prostate-cancer-age.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 16 Apr 2013 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news285353853</guid>
	 
</item>
<item>
     <title>Personalizing prostate specific antigen testing may improve specificity, reduce biopsies</title>
   	 <description>Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study published in The Journal of Urology reports that correcting PSA levels for these genetic variants can have significant consequences, including avoiding unnecessary biopsies for some men and eliminating false complacency for others.</description>
     <link>http://medicalxpress.com/news/2013-04-personalizing-prostate-specific-antigen-specificity.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 15 Apr 2013 08:20:01 EST</pubDate>
	 <guid isPermaLink="false">news285232076</guid>
	 
</item>
<item>
     <title>Genetics, age and ethnicity are risk factors in PCa, say experts</title>
   	 <description>&quot;Are there genetic risk factors for PCa? Yes, and BRCA2 and HOXB13 are useful for predicting high-risk disease,&quot; said Jack Cuzick (GB) president of the International Society for Cancer Prevention (ISCaP), referring to the two genes implicated in high-risk prostate disease. Cuzick gave a report on the Consensus Statement for Prostate Cancer Prevention at the closing plenary session of the 28 Annual EAU Congress held in Milan, Italy from March 15 to 19.</description>
     <link>http://medicalxpress.com/news/2013-03-genetics-age-ethnicity-factors-pca.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 21 Mar 2013 10:50:08 EST</pubDate>
	 <guid isPermaLink="false">news283081802</guid>
	 
</item>
<item>
     <title>Incidence and mortality of PCa after termination of PSA-based screening</title>
   	 <description>Men who participate in biennial PSA based screening have a lower risk of being diagnosed as well as dying from prostate cancer up to 9 years after their last PSA test, according to the results of a new study to be presented at the 28th Annual EAU Congress in Milan</description>
     <link>http://medicalxpress.com/news/2013-03-incidence-mortality-pca-termination-psa-based.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 18 Mar 2013 10:10:03 EST</pubDate>
	 <guid isPermaLink="false">news282818365</guid>
	 
</item>
<item>
     <title>Prostate-specific antigen screening: Values and techniques shape decisions</title>
   	 <description>What's most important to a man as he decides whether or not to undergo prostate-specific antigen- PSA- screening for prostate cancer? What does he value most about the screening? And what's the best way to present the information to help him make an appropriate decision for himself?</description>
     <link>http://medicalxpress.com/news/2013-02-prostate-specific-antigen-screening-values-techniques.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 11 Feb 2013 16:40:01 EST</pubDate>
	 <guid isPermaLink="false">news279822719</guid>
	 
</item>
<item>
     <title>Alternative PSA screening strategies could reduce harm</title>
   	 <description>(HealthDay)—Compared with standard screening, alternative prostate-specific antigen (PSA) screening strategies could maintain good prostate cancer detection rates while reducing overdiagnoses and unnecessary biopsies, according to research published in the Feb. 5 issue of the Annals of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-02-alternative-psa-screening-strategies.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 05 Feb 2013 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news279292220</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/alternativep.jpg" width="90" height="90" />
</item>
<item>
     <title>Eating deep-fried food associated with increased risk of prostate cancer, study finds</title>
   	 <description>Regular consumption of deep-fried foods such as French fries, fried chicken and doughnuts is associated with an increased risk of prostate cancer, and the effect appears to be slightly stronger with regard to more aggressive forms of the disease, according to a study by investigators at Fred Hutchinson Cancer Research Center.</description>
     <link>http://medicalxpress.com/news/2013-01-deep-fried-food-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 28 Jan 2013 16:19:41 EST</pubDate>
	 <guid isPermaLink="false">news278612370</guid>
	 
</item>
<item>
     <title>Stigma stymies prostate cancer screening, treatment in Ghana</title>
   	 <description>Infectious diseases in Ghana tend to capture the most attention, but a quiet crisis may soon take over as the country's most threatening epidemic: cancer.</description>
     <link>http://medicalxpress.com/news/2013-01-stigma-stymies-prostate-cancer-screening.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 24 Jan 2013 16:35:22 EST</pubDate>
	 <guid isPermaLink="false">news278267715</guid>
	 
</item>
<item>
     <title>Change in PSA levels over time can help predict aggressive prostate cancer</title>
   	 <description>Measurements taken over time of prostate specific antigen, the most commonly used screening test for prostate cancer in men, improve the accuracy of aggressive prostate cancer detection when compared to a single measurement of PSA, according to a Kaiser Permanente study published today in the British Journal of Urology International.</description>
     <link>http://medicalxpress.com/news/2013-01-psa-aggressive-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 15 Jan 2013 11:00:02 EST</pubDate>
	 <guid isPermaLink="false">news277452788</guid>
	 
</item>
<item>
     <title>MRI helps identify patients with prostate cancer who may benefit from active surveillance</title>
   	 <description>PSA screening has resulted in improved prostate cancer survival, but the high rate of diagnosis and treatment side effects raise concerns about overtreatment. In the quest to prevent overtreatment, &quot;active surveillance&quot; has emerged as a plausible option, encouraged for men whose tumors may not need immediate treatment and may never progress to more serious illness. Appropriate criteria for selecting patients for active surveillance are continuously debated. A group of investigators from Memorial Sloan-Kettering Cancer Center in New York report that adding endorectal magnetic resonance imaging (MRI) to the initial clinical evaluation of men with clinically low prostate cancer risk helps assess eligibility for active surveillance. Their results are published in The Journal of Urology.</description>
     <link>http://medicalxpress.com/news/2012-09-mri-patients-prostate-cancer-benefit.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 24 Sep 2012 16:54:54 EST</pubDate>
	 <guid isPermaLink="false">news267724488</guid>
	 
</item>
<item>
     <title>Physicians suggest expert recommendations ignore vital issues for patients</title>
   	 <description>In the medical world, where decisions invariably involve risk and uncertainty, two Beth Israel Deaconess Medical Center physicians note that experts generally base their recommendations on the outcome of death, which is &quot;readily determined, easily quantified, concrete.&quot;</description>
     <link>http://medicalxpress.com/news/2012-09-physicians-expert-vital-issues-patients.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 12 Sep 2012 17:00:07 EST</pubDate>
	 <guid isPermaLink="false">news266682721</guid>
	 
</item>
<item>
     <title>Benefit of PSA reduced by loss of quality-adjusted life-years</title>
   	 <description>(HealthDay) -- Although the European Randomized Study of Screening for Prostate Cancer (ERSPC) has reported a 29 percent reduction in prostate-cancer mortality for men who undergo prostate-specific antigen (PSA) screening, the benefit is attenuated by loss of quality-adjusted life-years (QALYs) due to post-diagnosis effects, according to a study published in the Aug. 16 issue of the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2012-08-benefit-psa-loss-quality-adjusted-life-years.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 16 Aug 2012 11:50:02 EST</pubDate>
	 <guid isPermaLink="false">news264332752</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/benefitofpsa.jpg" width="90" height="90" />
</item>
<item>
     <title>Many men with prostate cancer can avoid early surgery</title>
   	 <description>(Medical Xpress) -- New research suggests that many men with prostate cancer do not need immediate treatment, especially if they have low PSA scores or low-risk tumors that are unlikely to grow and spread. </description>
     <link>http://medicalxpress.com/news/2012-07-men-prostate-cancer-early-surgery.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 19 Jul 2012 04:05:20 EST</pubDate>
	 <guid isPermaLink="false">news261889508</guid>
	 
</item>
<item>
     <title>Expert panel suggests PSA test may benefit some men</title>
   	 <description>(HealthDay) -- Men with a life expectancy of more than 10 years should talk with their doctor about getting a prostate-specific antigen (PSA) test for prostate cancer, an expert panel recommends.</description>
     <link>http://medicalxpress.com/news/2012-07-expert-panel-psa-benefit-men.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 16 Jul 2012 17:35:13 EST</pubDate>
	 <guid isPermaLink="false">news261678904</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/expertpanels.jpg" width="90" height="90" />
</item>
<item>
     <title>New prostate cancer screening guidelines face a tough sell, study suggests</title>
   	 <description>(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter serious pushback from primary care physicians, according to results of a survey by Johns Hopkins investigators.</description>
     <link>http://medicalxpress.com/news/2012-05-prostate-cancer-screening-guidelines-tough.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 25 May 2012 08:33:48 EST</pubDate>
	 <guid isPermaLink="false">news257153617</guid>
	 
</item>
<item>
     <title>Final advice: Panel against routine prostate test</title>
   	 <description>Healthy men shouldn't get routine prostate cancer screenings, says updated advice from a government panel that found the PSA blood tests do more harm than good.</description>
     <link>http://medicalxpress.com/news/2012-05-advice-panel-routine-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 21 May 2012 18:18:52 EST</pubDate>
	 <guid isPermaLink="false">news256843126</guid>
	 
</item>
<item>
     <title>Final word: Task force recommends against PSA-based screening for prostate cancer</title>
   	 <description>Following a period for public comment, the United States Preventive Services Task Force (USPSTF) released its final recommendation for prostate cancer screening. The Task Force now recommends against PSA-based screening for all men, regardless of age. The final recommendations are being published early online in the May 22 issue of Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP).</description>
     <link>http://medicalxpress.com/news/2012-05-word-task-psa-based-screening-prostate.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 21 May 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news256823670</guid>
	 
</item>
<item>
     <title>PSA screening to detect prostate cancer can be beneficial to younger and at-risk men: study</title>
   	 <description>Screening younger men and men at risk of prostate cancer can be beneficial in reducing metastatic cancer and deaths and should not be abandoned, states an article published in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://medicalxpress.com/news/2012-05-psa-screening-prostate-cancer-beneficial.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 07 May 2012 12:00:03 EST</pubDate>
	 <guid isPermaLink="false">news255605414</guid>
	 
</item>
<item>
     <title>Age, life expectancy influence termination of PSA screening</title>
   	 <description>(HealthDay) -- Most primary care providers consider both a man's age and life expectancy in deciding whether to discontinue prostate-specific antigen (PSA) screenings, but multiple factors are involved in this decision, according to a study published online April 19 in Cancer.</description>
     <link>http://medicalxpress.com/news/2012-04-age-life-termination-psa-screening.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 26 Apr 2012 12:56:14 EST</pubDate>
	 <guid isPermaLink="false">news254663763</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/agelifeexpec.jpg" width="90" height="90" />
</item>
<item>
     <title>Study finds PSA testing cuts prostate cancer death risk, but does it save lives?</title>
   	 <description>(HealthDay) -- Adding another perspective to one of the most controversial and confounding issues in medicine, a new European study reports that men who received routine prostate-specific antigen (PSA) tests to check for signs of prostate cancer were 30 percent less likely to die from the disease. </description>
     <link>http://medicalxpress.com/news/2012-03-psa-prostate-cancer-death.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 14 Mar 2012 18:40:01 EST</pubDate>
	 <guid isPermaLink="false">news250968082</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/studyfindsps.jpg" width="90" height="90" />
</item>
<item>
     <title>Biopsy referral after PSA screening stays consistent over time</title>
   	 <description>After the US Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), many debated which PSA level should lead to a biopsy recommendation. The US Preventive Screening Task Force (USPSTF) recently concluded, amid considerable controversy, that the evidence does not support recommending PSA screening for men under 75 years old at all, because the risks outweigh the benefits. Now, a study shows that physicians in a large Washington state health plan were being conservative in biopsy referral even before the USPSTF recommendation.</description>
     <link>http://medicalxpress.com/news/2011-12-biopsy-referral-psa-screening.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 13 Dec 2011 03:48:21 EST</pubDate>
	 <guid isPermaLink="false">news242970493</guid>
	 
</item>
<item>
     <title>New prostate cancer test advice overturns dogma</title>
   	 <description>(AP) --  Men finally may be getting a clearer message about undergoing PSA screening for prostate cancer: Don't do it.</description>
     <link>http://medicalxpress.com/news/2011-10-panel-prostate-cancer-screening.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 07 Oct 2011 04:10:42 EST</pubDate>
	 <guid isPermaLink="false">news237179019</guid>
	 
</item>
<item>
     <title>New prostate cancer test gives more accurate diagnosis</title>
   	 <description>In a large multi-center clinical trial, a new PSA test to screen for prostate cancer more accurately identified men with prostate cancer -- particularly the aggressive form of the disease -- and substantially reduced false positives compared to the twocurrently available commercial PSA tests, according to newly published research from Northwestern Medicine.</description>
     <link>http://medicalxpress.com/news/2011-04-prostate-cancer-accurate-diagnosis.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 06 Apr 2011 13:09:53 EST</pubDate>
	 <guid isPermaLink="false">news221314179</guid>
	 
</item>


</channel>
</rss>
